Cargando…
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis
INTRODUCTION: Despite the advent of biological therapies for the treatment of rheumatoid arthritis, there is a compelling need to develop alternative therapeutic targets for nonresponders to existing treatments. Soluble receptors occur naturally in vivo, such as the splice variant of the cell surfac...
Autores principales: | Jin, Pei, Zhang, Juan, Sumariwalla, Percy F, Ni, Irene, Jorgensen, Brett, Crawford, Damian, Phillips, Suzanne, Feldmann, Marc, Shepard, H Michael, Paleolog, Ewa M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575619/ https://www.ncbi.nlm.nih.gov/pubmed/18593464 http://dx.doi.org/10.1186/ar2447 |
Ejemplares similares
-
The angiogenesis inhibitor protease-activated kringles 1–5 reduces the severity of murine collagen-induced arthritis
por: Sumariwalla, Percy F, et al.
Publicado: (2003) -
Angiogenesis in rheumatoid arthritis
por: Paleolog, Ewa M
Publicado: (2002) -
It's all in the blood: circulating endothelial progenitor cells link synovial vascularity with cardiovascular mortality in rheumatoid arthritis?
por: Paleolog, Ewa
Publicado: (2005) -
Tyrosine kinases in rheumatoid arthritis
por: Okamoto, Hiroshi, et al.
Publicado: (2011) -
Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis
por: Muz, Barbara, et al.
Publicado: (2009)